Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Product sales, net $ 48,244 $ 20,679
Cost of goods sold 14,366 6,190
Gross profit 33,878 14,489
Operating expenses:    
Research and development 1,885 724
Selling, general and administrative 21,746 16,193
Royalty buy-out 0 2,432
Total Operating Expenses 23,631 19,349
Operating income (loss) 10,247 (4,860)
Other expense:    
Interest expense 153 507
Other 0 12
Total other expense 153 519
Income (loss) before income taxes 10,094 (5,379)
Income tax benefit (expense) (93) 482
Net income (loss) $ 10,001 $ (4,897)
Weighted average common shares outstanding for basic (shares) 91,916 80,432
Weighted average common shares outstanding for diluted (shares) 114,470 80,432
Net income (loss) per common share    
Basic (in USD per share) $ 0.11 $ (0.06)
Diluted (in USD per share) $ 0.09 $ (0.06)